Microdevice for Psoriasis and Atopic Dermatitis
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is being done to test a microdevice, which is a small device designed to test drugs directly on skin conditions like atopic dermatitis (eczema) and psoriasis.
The small device, about the size of a grain of rice, has up to 20 tiny reservoirs that hold medications that are approved by the Food and Drug Administration (FDA) for atopic dermatitis and psoriasis. Very small amounts of these medications will be released into the skin (at levels in your body much lower than are typically used). In this study, the device will be tested to see if it's safe and works well for predicting how the skin will react to standard treatments. We will also look at how these reactions are connected to genetic information and overall treatment results.
Who Is on the Research Team?
Raymond Cho, MD, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for adults over 18 with psoriasis or atopic dermatitis. Women of childbearing age must be on birth control pills or have an intrauterine device for at least a month to participate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
The microdevice is placed on the skin to release small amounts of FDA-approved medications for atopic dermatitis and psoriasis to test safety and efficacy.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of adverse events and tissue analysis.
What Are the Treatments Tested in This Trial?
Interventions
- In situ cutaneous microdevice
Trial Overview
The study tests a microdevice, like a tiny skin patch, that delivers small amounts of FDA-approved medications directly into the skin to see how well it predicts treatment responses and correlates with genetic data.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
The small device, about the size of a grain of rice, has up to 20 tiny reservoirs that hold medications that are approved by the Food and Drug Administration (FDA) for atopic dermatitis and psoriasis. Very small amounts of these medications will be released into the skin (at levels in your body much lower than are typically used). In this study, the device will be tested to see if it's safe and works well for predicting how the skin will react to standard treatments. We will also look at how these reactions are connected to genetic information and overall treatment results.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.